(Q30408294)

English

Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission (English)

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

object named as

Geoffrey L Uy

37

0 references

Robert Peter Gale

27

object named as

Robert Peter Gale

1 reference

Europe PubMed Central

21 August 2017

PMC publication ID

Martin Bornhäuser

21

object named as

Martin Bornhauser

1 reference

Europe PubMed Central

21 August 2017

PMC publication ID

Hillard M. Lazarus

17

object named as

Hillard M Lazarus

1 reference

Europe PubMed Central

21 August 2017

PMC publication ID

16

object named as

Harry C Schouten

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

36

object named as

Armin Ghobadi

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

40

object named as

Mark R Litzow

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Ruta Brazauskas

3

object named as

Ruta Brazauskas

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Jane L. Liesveld

34

object named as

Jane L Liesveld

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Edmund K Waller

11

object named as

Edmund K Waller

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Daniel J Weisdorf

39

object named as

Daniel J Weisdorf

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Mitchell S Cairo

23

object named as

Mitchell S Cairo

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

32

object named as

Wael Saber

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Rammurti T Kamble

28

object named as

Rammurti T Kamble

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

8

object named as

Bipin N Savani

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

13

object named as

César O Freytes

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

4

object named as

Xiaobo Zhong

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Mitchell Sabloff

25

object named as

Mitchell Sabloff

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

19

object named as

John Koreth

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Bruce M Camitta

6

object named as

Bruce M Camitta

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

35

object named as

Corey S Cutler

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

20

object named as

Jean-Yves Cahn

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Matthew D Seftel

22

object named as

Matthew Seftel

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

15

object named as

Gorgun Akpek

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

29

object named as

Ravi Vij

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

26

object named as

Olle Ringdén

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

38

object named as

Mary Eapen

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Celalettin Ustun

9

object named as

Celalettin Ustun

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

author name string

Erica D Warlick

1

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Kristjan Paulson

2

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Alan M Miller

5

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Biju George

7

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

David I Marks

10

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Frédéric Baron

12

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Gérard Socie

14

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Edwin M Horwitz

18

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Mary J Laughlin

24

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Usama Gergis

30

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Vikram Mathews

31

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Yi-Bin Chen

33

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

publication date

1 November 2013

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

20

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

202-208

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Sense and nonsense of high-dose cytarabine for acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

20 June 2018

Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

20 June 2018

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

20 June 2018

Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

20 June 2018

Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

20 June 2018

Defining the intensity of conditioning regimens: working definitions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

20 June 2018

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

20 June 2018

Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

20 June 2018

Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

20 June 2018

Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

20 June 2018

Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

20 June 2018

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

20 June 2018

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

20 June 2018

Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

20 June 2018

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

20 June 2018

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

20 June 2018

A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

26 November 2018

Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

26 November 2018

Pre-transplant consolidation chemotherapy may not improve outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

26 November 2018

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

26 November 2018

Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

26 November 2018

Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

26 November 2018

Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3924751

26 November 2018

No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://pubmed.ncbi.nlm.nih.gov/24184335

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BBMT.2013.10.023

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30408294&oldid=1858006694"